ATAI Total Current Liabilities from 2010 to 2024
| ATAI Stock | USD 1.61 0.09 5.92% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 20.1 M | Current Value 16.5 M | Quarterly Volatility 8.2 M |
Check ATAI Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ATAI Life's main balance sheet or income statement drivers, such as Tax Provision of 6.9 M, Interest Income of 1.4 M or Depreciation And Amortization of 334.9 K, as well as many indicators such as Price To Sales Ratio of 680, Dividend Yield of 0.0 or PTB Ratio of 0.97. ATAI financial statements analysis is a perfect complement when working with ATAI Life Valuation or Volatility modules.
ATAI | Total Current Liabilities |
Latest ATAI Life's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of ATAI Life Sciences over the last few years. Total Current Liabilities is an item on ATAI Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ATAI Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. ATAI Life's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ATAI Life's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
ATAI Total Current Liabilities Regression Statistics
| Arithmetic Mean | 7,052,569 | |
| Geometric Mean | 3,569,953 | |
| Coefficient Of Variation | 116.26 | |
| Mean Deviation | 7,260,759 | |
| Median | 1,607,000 | |
| Standard Deviation | 8,199,200 | |
| Sample Variance | 67.2T | |
| Range | 19.3M | |
| R-Value | 0.81 | |
| Mean Square Error | 24.9T | |
| R-Squared | 0.66 | |
| Significance | 0.0002 | |
| Slope | 1,485,514 | |
| Total Sum of Squares | 941.2T |
ATAI Total Current Liabilities History
About ATAI Life Financial Statements
Investors use fundamental indicators, such as ATAI Life's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although ATAI Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 20.1 M | 16.5 M |
Currently Active Assets on Macroaxis
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:Check out the analysis of ATAI Life Correlation against competitors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.80) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.54) | Return On Assets (0.25) |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.